Pulling SEC filings + quote and writing the call…

Black Hawk Acquisition Corp
Next earnings Jun 24, 2026
Pre-deal SPAC with no business, zero operating cash and negative equity, merging into clinical-stage Vesicor — a binary bet, not an investment.
Net income (FY2025) $1.33M · FY2025
BKHA is not an operating company — it's a Cayman blank-check SPAC that IPO'd in March 2024 at $10.00/unit. Management states plainly: 'We have neither engaged in any operations nor generated any revenues to date.' The entire reported FY2025 'net income' of $1.33M is simply T-bill interest income of $2.24M on the trust account, offset by $795K of G&A and $120K of related-party admin fees — not a profit from any business. Interest income already fell YoY ($2.49M→$2.24M) and net income dropped 30.6%, because the trust is shrinking: total assets collapsed 66.9% to $23.9M and shares outstanding fell 53.5% to 4.15M, the signature of heavy shareholder redemptions ahead of the vote.
The balance sheet outside the trust is bare. The MD&A discloses just $39,521 of cash and a $1.43M working capital deficit as of Nov 30, 2025; the XBRL confirms $0.00 cash & equivalents, current assets of only $50.8K against current liabilities of $1.48M (up nearly 20x YoY), and stockholders' equity of -$3.85M. Negative equity is partly a SPAC accounting artifact (redeemable public shares sit in temporary equity), but the zero non-trust cash and blown-out current ratio are real — the company concedes it 'will need additional capital to satisfy its liquidity needs,' relying on sponsor loans.
| Line item | FY24 | FY25 |
|---|---|---|
| Revenue | — | — |
| Gross profit | — | — |
| Operating income | -$576K | -$916K |
| Net income | $1.92M | $1.33M |
| Diluted EPS | — | — |
| Net margin | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sponsor working-capital loan + new share issuance to extend runway; adds debt, dilutes
Amended FY25 10-K; revised/added disclosures, no change to operations
Q1 FY26 report; negative equity, trust depleted, Vesicor deal still pending
Filed late-filing (NT) notice for Q1 10-Q
Received Nasdaq continued-listing deficiency/delisting notice
Officer/director change plus Reg FD disclosure; no financial impact
FY25 net income $1.33M all trust interest; equity -$3.85M, working-capital deficit
Filed late-filing (NT) notice for FY25 10-K
Another sponsor note + share issuance to fund extension; more debt and dilution
Sources: SEC EDGAR (CIK 0002000775, latest 10-Q filed 2026-04-21) · EODHD · Proprietary analysis · as of 7/4/2026, 3:33:41 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2024-04-04 | Black Hawk Management LLC 10% owner | Award | 1.73M |
1195 tracked peers · median